SEC Form 4 · accession 0001179110-15-013149
IMMUNOGEN INC · IMGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel M Junius
Officer — Chief Executive Officer · Director
Period of report
Sep 9, 2015
Accepted (ET)
Sep 9, 2015 · 1:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000855654
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 9, 2015 | M | 4,899 | $5.77 | A | 159,014 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $5.77 | Sep 9, 2015 | M | 4,899 | D | Jun 12, 2008 | Jun 12, 2017 | Common Stock | 4,899 | 62,791 | D |
Explanation of responses
- F1Exercisable as to 26,667 shares commencing on June 12, 2008, 26,667 shares commencing on June 12, 2009, and 26,666 shares commencing on June 12, 2010.